Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers.

Journal: Gynecologic oncology
Published Date:

Abstract

OBJECTIVE: Determine the utility of a clinical calculator to predict the benefit of chemotherapy in stage IA uterine papillary serous cancer (UPSC).

Authors

  • D P Mysona
    The University of North Carolina, Chapel Hill, NC, USA; The Medical College of Georgia at Augusta University, Augusta, GA, USA.
  • L K H Tran
    The Medical College of Georgia at Augusta University, Augusta, GA, USA.
  • P M H Tran
    The Medical College of Georgia at Augusta University, Augusta, GA, USA.
  • P A Gehrig
    University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • L Van Le
    University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • S Ghamande
    The Medical College of Georgia at Augusta University, Augusta, GA, USA.
  • B J Rungruang
    The Medical College of Georgia at Augusta University, Augusta, GA, USA.
  • J Java
    Genomics Research Center, University of Rochester Medical Center, Rochester, NY, USA.
  • A K Mann
    Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA.
  • J Liao
    Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA.
  • D S Kapp
    Stanford University School of Medicine, Stanford, CA, USA.
  • Bruno Dos Santos
    Jinfinti Precision Medicine, Inc, Augusta, GA, USA.
  • J X She
    The Medical College of Georgia at Augusta University, Augusta, GA, USA; Jinfinti Precision Medicine, Inc, Augusta, GA, USA. Electronic address: jshe@augusta.edu.
  • J K Chan
    Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA; California Pacific & Palo Alto Medical Foundation/Sutter Health Research Institute, San Francisco, CA, USA. Electronic address: chanjohn@sutterhealth.org.